BioSpace News Archive

Business

World renowned neuroscientist & mathematician recognised as The Oxford Science Park’s Magdalen Centre is given new identity

Sherrington and Whitehead Buildings combine with new Bellhouse Building in 100,000 sq ft innovation centre

October 16, 2019
·
4 min read
Frontotemporal dementia is associated with alterations in immune system function

Recent research from the University of Eastern Finland revealed increased inflammatory activity in a subgroup of patients with frontotemporal dementia Increased inflammation was associated with parkinsonism symptoms and more rapid disease progression.

October 16, 2019
·
3 min read
Biotech Bay

Emedgene announces algorithm that estimates chances of a genetic case being solved

Less than 40% of genetic cases are solved initially; Emedgene’s new algorithm ‘Pathorolo’ enables automated reanalysis of past cases by identifying the cases most likely to be solved

October 16, 2019
·
1 min read
Policy

Pharming responds to press speculation

Pharming categorically denies having had any involvement in the alleged abstraction of proprietary information by Dr Joseph Chiao from his former employer CSL

October 16, 2019
·
5 min read
AI system more accurately identifies collapsed lungs using chest x-rays

New assistive technology can diagnose collapsed lungs from chest x-rays with a higher degree of accuracy than radiologists.

October 16, 2019
·
2 min read
Business

Pharnext announces 2019 half-year results

Pharnext SA, a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big genomics data and artificial intelligence, announced its financial results for first-half 2019.

October 16, 2019
·
3 min read
Pharm Country

Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance

CertainT Platform Complemented by Stable-Isotopic Indicators Offers Brand Owners Increased Supply Chain Transparency and Product and Process Authentication

October 16, 2019
·
5 min read
Drug Development

Aurinia Reports Last Patient Study Visit in Aurora Phase 3 Lupus Nephritis Study and Provides Update on ATM Facility

AURORA Phase 3 results with voclosporin for the treatment of lupus nephritis remain on track to be reported by the end of the fourth quarter 2019

October 16, 2019
·
9 min read
Deals

Alexion to Acquire Achillion

Provides opportunity to enhance treatment for PNH patients experiencing extravascular hemolysis (EVH), potential first-in-class C3 glomerulopathy (C3G) therapy & promising development platform for Factor D inhibition in additional alternative pathway complement-mediated rare diseases

October 16, 2019
·
15 min read
Business

Kane Biotech and Dechra Veterinary Products Expand Exclusive License and Distribution Agreement to Include South America

Kane Biotech Inc., and Dechra Veterinary Products LLC announced the expansion of their 10-year Exclusive License and Distribution Agreement to include South America.

October 16, 2019
·
3 min read